Long‐term results of elective mucosal irradiation for head and neck cancer of unknown primary in Chinese population: The EMICUP study
Abstract Objective Controversy still exists regarding the volume of radiation for head and neck cancer of unknown primary (HNCUP). Theoretically, elective mucosal irradiation (EMI) should achieve a balance between survival and toxicity. This prospective study was conducted to evaluate the long‐term...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-03-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.2856 |
_version_ | 1811153640059043840 |
---|---|
author | Shengjin Dou Rongrong Li Lin Zhang Zhuoying Wang Li Xie Chenping Zhang Guopei Zhu |
author_facet | Shengjin Dou Rongrong Li Lin Zhang Zhuoying Wang Li Xie Chenping Zhang Guopei Zhu |
author_sort | Shengjin Dou |
collection | DOAJ |
description | Abstract Objective Controversy still exists regarding the volume of radiation for head and neck cancer of unknown primary (HNCUP). Theoretically, elective mucosal irradiation (EMI) should achieve a balance between survival and toxicity. This prospective study was conducted to evaluate the long‐term benefit of EMI in Chinese HNCUP patients. Methods A phase II, single‐arm trial was performed at two centers in China. HNCUP patients with pathologically confirmed metastatic squamous cell carcinoma or poorly differentiated carcinoma were enrolled. Patients with metastatic lymph nodes limited to level IV and/or the supraclavicular fossa were excluded. The EMI approach was specifically customized to Chinese patients by differentiating HNCUP as putative nasopharyngeal carcinoma (NPC) or non‐putative NPC. The primary endpoint was 3‐year mucosal recurrence‐free survival (MRFS). Results A total of 48 patients were enrolled between 02/02/2010 and 08/01/2018; 46 patients were analyzed, including 24 putative NPC and 22 non‐putative NPC patients. No primary recurrence was observed during a median follow‐up period of 70 months, and only 1 patient experienced out of field recurrence in the contralateral neck. The 3‐year MRFS was 90.6% (95%CI: 76.4%‐96.4%). The 5‐year MRFS, regional‐recurrence free survival (RRFS) and overall survival (OS) were 90.6% (95%CI: 76.4%‐96.4%), 86.0% (95%CI: 71.1%‐93.7%), and 90.6% (95%CI: 76.4%‐96.4%), respectively. No grade 4 acute or late toxicities occurred, and the most frequent grade 3 acute toxicity was oral mucositis (45.7%). Conclusion To the best of our knowledge, this is the first prospective study to evaluate the long‐term outcomes of EMI in Chinese HNCUP patients. Excellent MRFS and OS rates were observed. Further randomized studies are warranted. |
first_indexed | 2024-03-08T04:03:13Z |
format | Article |
id | doaj.art-071217e7aec44764b65c53b177e7ea72 |
institution | Directory Open Access Journal |
issn | 2045-7634 |
language | English |
last_indexed | 2024-03-08T04:03:13Z |
publishDate | 2020-03-01 |
publisher | Wiley |
record_format | Article |
series | Cancer Medicine |
spelling | doaj.art-071217e7aec44764b65c53b177e7ea722024-02-09T09:26:02ZengWileyCancer Medicine2045-76342020-03-01951712172010.1002/cam4.2856Long‐term results of elective mucosal irradiation for head and neck cancer of unknown primary in Chinese population: The EMICUP studyShengjin Dou0Rongrong Li1Lin Zhang2Zhuoying Wang3Li Xie4Chenping Zhang5Guopei Zhu6Radiotherapy Division Department of Oral and Maxillofacial‐Head Neck Oncology Shanghai Ninth People’s Hospital College of Stomatology Shanghai Jiao Tong University School of Medicine Shanghai ChinaRadiotherapy Division Department of Oral and Maxillofacial‐Head Neck Oncology Shanghai Ninth People’s Hospital College of Stomatology Shanghai Jiao Tong University School of Medicine Shanghai ChinaRadiotherapy Division Department of Oral and Maxillofacial‐Head Neck Oncology Shanghai Ninth People’s Hospital College of Stomatology Shanghai Jiao Tong University School of Medicine Shanghai ChinaDepartment of Head and Neck Surgery Fudan University Shanghai Cancer Center Shanghai ChinaClinical Research Center Shanghai Jiao Tong University School of Medicine Shanghai ChinaNational Clinical Research Center for Oral Diseases Shanghai ChinaRadiotherapy Division Department of Oral and Maxillofacial‐Head Neck Oncology Shanghai Ninth People’s Hospital College of Stomatology Shanghai Jiao Tong University School of Medicine Shanghai ChinaAbstract Objective Controversy still exists regarding the volume of radiation for head and neck cancer of unknown primary (HNCUP). Theoretically, elective mucosal irradiation (EMI) should achieve a balance between survival and toxicity. This prospective study was conducted to evaluate the long‐term benefit of EMI in Chinese HNCUP patients. Methods A phase II, single‐arm trial was performed at two centers in China. HNCUP patients with pathologically confirmed metastatic squamous cell carcinoma or poorly differentiated carcinoma were enrolled. Patients with metastatic lymph nodes limited to level IV and/or the supraclavicular fossa were excluded. The EMI approach was specifically customized to Chinese patients by differentiating HNCUP as putative nasopharyngeal carcinoma (NPC) or non‐putative NPC. The primary endpoint was 3‐year mucosal recurrence‐free survival (MRFS). Results A total of 48 patients were enrolled between 02/02/2010 and 08/01/2018; 46 patients were analyzed, including 24 putative NPC and 22 non‐putative NPC patients. No primary recurrence was observed during a median follow‐up period of 70 months, and only 1 patient experienced out of field recurrence in the contralateral neck. The 3‐year MRFS was 90.6% (95%CI: 76.4%‐96.4%). The 5‐year MRFS, regional‐recurrence free survival (RRFS) and overall survival (OS) were 90.6% (95%CI: 76.4%‐96.4%), 86.0% (95%CI: 71.1%‐93.7%), and 90.6% (95%CI: 76.4%‐96.4%), respectively. No grade 4 acute or late toxicities occurred, and the most frequent grade 3 acute toxicity was oral mucositis (45.7%). Conclusion To the best of our knowledge, this is the first prospective study to evaluate the long‐term outcomes of EMI in Chinese HNCUP patients. Excellent MRFS and OS rates were observed. Further randomized studies are warranted.https://doi.org/10.1002/cam4.2856head and neckintensity‐modulated radiation therapylymph node metastasismucosal irradiationradiotherapyunknown primary |
spellingShingle | Shengjin Dou Rongrong Li Lin Zhang Zhuoying Wang Li Xie Chenping Zhang Guopei Zhu Long‐term results of elective mucosal irradiation for head and neck cancer of unknown primary in Chinese population: The EMICUP study Cancer Medicine head and neck intensity‐modulated radiation therapy lymph node metastasis mucosal irradiation radiotherapy unknown primary |
title | Long‐term results of elective mucosal irradiation for head and neck cancer of unknown primary in Chinese population: The EMICUP study |
title_full | Long‐term results of elective mucosal irradiation for head and neck cancer of unknown primary in Chinese population: The EMICUP study |
title_fullStr | Long‐term results of elective mucosal irradiation for head and neck cancer of unknown primary in Chinese population: The EMICUP study |
title_full_unstemmed | Long‐term results of elective mucosal irradiation for head and neck cancer of unknown primary in Chinese population: The EMICUP study |
title_short | Long‐term results of elective mucosal irradiation for head and neck cancer of unknown primary in Chinese population: The EMICUP study |
title_sort | long term results of elective mucosal irradiation for head and neck cancer of unknown primary in chinese population the emicup study |
topic | head and neck intensity‐modulated radiation therapy lymph node metastasis mucosal irradiation radiotherapy unknown primary |
url | https://doi.org/10.1002/cam4.2856 |
work_keys_str_mv | AT shengjindou longtermresultsofelectivemucosalirradiationforheadandneckcancerofunknownprimaryinchinesepopulationtheemicupstudy AT rongrongli longtermresultsofelectivemucosalirradiationforheadandneckcancerofunknownprimaryinchinesepopulationtheemicupstudy AT linzhang longtermresultsofelectivemucosalirradiationforheadandneckcancerofunknownprimaryinchinesepopulationtheemicupstudy AT zhuoyingwang longtermresultsofelectivemucosalirradiationforheadandneckcancerofunknownprimaryinchinesepopulationtheemicupstudy AT lixie longtermresultsofelectivemucosalirradiationforheadandneckcancerofunknownprimaryinchinesepopulationtheemicupstudy AT chenpingzhang longtermresultsofelectivemucosalirradiationforheadandneckcancerofunknownprimaryinchinesepopulationtheemicupstudy AT guopeizhu longtermresultsofelectivemucosalirradiationforheadandneckcancerofunknownprimaryinchinesepopulationtheemicupstudy |